Foresight Diagnostics
Jeff Bird is a Board Member at Foresight Diagnostics. Jeff has previously worked at Leyden Labs, Foresight Dx, Kriya Therapeutics, Nutcracker Therapeutics, Epirium, Bluebird Ventures, Procyrion, Inc., GRAIL, Inc., and Sutter Hill Ventures.
Jeff Bird's educational career began with a Bachelor of Science (BS) from Stanford University. Jeff then went on to earn their MD at Stanford University School of Medicine. Jeff also has a Ph.D. in Cancer Biology from Stanford University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Foresight Diagnostics
1 followers
Foresight Diagnostics is the world’s most sensitive liquid biopsy minimal residual disease (MRD) test that detects the earliest hints of cancer relapse.